COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Read Here
Advertise
Sign Up
Commentary
The Claude ban is a crash course in digital resilience — and that’s good for Hong Kong bankers
Getting governance right in Hong Kong’s regulatory environment